Experimental chewing gum "VitRx" reduces Omicron in saliva; sexual dysfunction and hair loss*

*Among long COVID symptoms. The experimental chewing gum traps the SARS-CoV-2 particles in saliva holds promise for curbing transmission of new variants of the virus, according to new data, as researchers prepare to launch the first human trial.
 
STUTTGART, Germany - July 28, 2022 - PRLog -- Richard H. Davis, President and CEO of Nautilus GmbH Laboratoriumsbedarf & Co. KG., states that his company intends to produce and market a new patent-pending ACE2-infused chewing-gum; called VitRx. The gum contains copies of the ACE2 protein found on cell surfaces, which the coronavirus uses to break into cells and infect them. In test-tube experiments using saliva from individuals infected with the Delta or Omicron variants, the virus particles attached themselves to the ACE2 ``receptors" in the chewing gum and the viral load fell to undetectable levels, researchers reported in Biomaterials. In the clinical trial, COVID-19 patients will each chew four ACE2 gum tablets each day for four days. The "viral trap" ACE2 proteins in the gum are carried within engineered lettuce cells. A second experimental chewing gum made with bean powder instead of lettuce cells not only traps SARS-CoV-2 particles in lab experiments but also influenza strains, other coronaviruses that cause common colds, and potentially other oral viruses such as human papillomavirus and herpesvirus, according to the paper.

"Because nasal transmission is negligible when compared to oral transmission... chewing ACE2 gum and swallowing ACE2 protein should minimize infection, protect COVID-19 patients and prevent transmission," said research leader Dr. Henry Daniell of the School of Dental Medicine at the University of Pennsylvania. Long COVID symptoms include sexual dysfunction, hair loss. Add loss of hair and libido to the symptoms associated with long COVID, UK researchers warn.

"This research validates what patients have been telling clinicians and policy makers throughout the pandemic, that the symptoms of long COVID are extremely broad and cannot be fully accounted for by other factors such as lifestyle risk factors or chronic health conditions," study leader Dr. Shamil Haroon of the University of Birmingham said in a statement.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Source Material: REUTERS/Nancy Lapid released July 26, 2022 (https://archive.ph/rl6Xf)

For more information visit https://vitrx.webnode.co.uk or Check out our video on youtube at https://www.youtube.com/watch?v=R9dh_6-3Gkg



Media Contact
Wolfram Juretzek
diqatibe@ema-sofia.eu
+49 7255 2992042
End
Email:***@ema-sofia.eu Email Verified
Tags:Vitrx
Industry:Health
Location:Stuttgart - Baden-Württemberg - Germany
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Nautilus GmbH Laboratoriumsbedarf & Co. KG PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share